Bank of New York Mellon Corp - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 59 filers reported holding NEOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$9,000
+28.6%
13,6450.0%0.00%
Q3 2020$7,000
-22.2%
13,6450.0%0.00%
Q2 2020$9,000
-10.0%
13,6450.0%0.00%
Q1 2020$10,000
-52.4%
13,6450.0%0.00%
Q4 2019$21,000
+5.0%
13,6450.0%0.00%
Q3 2019$20,000
+11.1%
13,6450.0%0.00%
Q2 2019$18,000
-94.5%
13,645
-89.2%
0.00%
Q1 2019$330,000
+68.4%
126,263
+6.0%
0.00%
Q4 2018$196,000
-46.2%
119,063
+58.4%
0.00%
Q3 2018$364,000
-22.4%
75,186
+0.1%
0.00%
Q2 2018$469,000
-21.6%
75,130
+4.4%
0.00%
Q1 2018$598,000
-16.2%
71,975
+3.0%
0.00%
Q4 2017$714,000
-4.4%
69,901
-14.4%
0.00%
Q3 2017$747,000
+72.5%
81,617
+37.7%
0.00%
Q2 2017$433,000
+0.5%
59,254
-1.0%
0.00%
Q1 2017$431,000
+68.4%
59,841
+37.1%
0.00%
Q4 2016$256,000
+21.9%
43,650
+37.1%
0.00%
Q3 2016$210,000
-40.5%
31,845
-16.2%
0.00%
Q2 2016$353,000
+48.9%
38,008
+73.1%
0.00%
Q1 2016$237,0000.0%21,962
+32.7%
0.00%
Q4 2015$237,000
-3.7%
16,545
+41.3%
0.00%
Q3 2015$246,00011,7130.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders